Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.

Cao L, Weetall M, Trotta C, Cintron K, Ma J, Kim MJ, Furia B, Romfo C, Graci JD, Li W, Du J, Sheedy J, Hedrick J, Risher N, Yeh S, Qi H, Arasu T, Hwang S, Lennox W, Kong R, Petruska J, Moon YC, Babiak J, Davis TW, Jacobson A, Almstead NG, Branstrom A, Colacino JM, Peltz SW.

Mol Cancer Ther. 2019 Jan;18(1):3-16. doi: 10.1158/1535-7163.MCT-18-0863. Epub 2018 Oct 23.

PMID:
30352802
2.

Exonic splicing enhancers in fission yeast: functional conservation demonstrates an early evolutionary origin.

Webb CJ, Romfo CM, van Heeckeren WJ, Wise JA.

Genes Dev. 2005 Jan 15;19(2):242-54. Epub 2004 Dec 29.

4.
5.
6.

Evidence for splice site pairing via intron definition in Schizosaccharomyces pombe.

Romfo CM, Alvarez CJ, van Heeckeren WJ, Webb CJ, Wise JA.

Mol Cell Biol. 2000 Nov;20(21):7955-70.

8.

Locations of the regulatory sites for isocitrate dehydrogenase kinase/phosphatase.

Miller SP, Chen R, Karschnia EJ, Romfo C, Dean A, LaPorte DC.

J Biol Chem. 2000 Jan 14;275(2):833-9.

9.

Functional recognition of the 3' splice site AG by the splicing factor U2AF35.

Wu S, Romfo CM, Nilsen TW, Green MR.

Nature. 1999 Dec 16;402(6763):832-5.

PMID:
10617206
11.

Supplemental Content

Support Center